Find out how mariPOC can help society and enterprises to keep running.
mariPOC® test system
Our test system enables fast and accurate diagnosis in acute infections. Multiple pathogens are tested from a single clinical sample simultaneously. The fully automated test system enables central laboratory sensitivity and specificity in rapid and decentralized testing. The quality of the results is ensured by a unique internal autoverification system. These together with ease of use make mariPOC perfectly suitable also for point-of-care testing (POCT).
Preparing for the flu season
Not sure if it's COVID-19, influenza or a common cold? Find out with mariPOC Respi+ test! Respi+ is a broad test panel covering 11 pathogens for syndromic testing of acute respiratory tract infections. Accurate and fast diagnosis enables optimal treatment and quick isolation measures.
News
mariPOC COVID-19 tests are suitable for travel certificates in the EU
The use of the mariPOC SARS-CoV-2, Respi+ and Quick Flu+ tests for EU COVID certificates...
Press release: ArcDia launches a quick and automated COVID-19 antigen test with superior performance
Turku, Finland, March 3rd, 2021 – the Finnish medical device manufacturer ArcDia International Ltd has...
Press release: Bruker to distribute ArcDia’s mariPOC® products for automated antigen POCT of COVID-19 and other infectious diseases in Central Europe
Turku, September 10th 2020 – ArcDia International Oy Ltd (“ArcDia”), developer and manufacturer of the...
Events
NSCMID 2021
Come meet us at NSCMID conference 2021 (3rd- 6th September, Turku)! Our team will be...
2nd International Conference Trends in Influenza Research
ArcDia’s R&D director Janne O. Koskinen speech at the online conference. mariPOC® technology designed for...
World Society for Virology: Tackling Global Viral Epidemics
ArcDia’s R&D director Janne O. Koskinen talk at the online conference. Online event World Society...